791148375	791148375	CD	B-NP	O
|	|	NN	I-NP	O
MDR	MDR	NN	I-NP	O
|	|	NN	I-NP	O
45113416	45113416	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
405614	405614	CD	B-NP	O
|	|	CC	I-NP	O
11/23/2002	11/23/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
B	B	NN	I-NP	I-protein
ankle	ankle	NN	I-NP	I-protein
RA	RA	NN	I-NP	I-protein
flare	flare	VBP	B-VP	O
|	|	NN	B-NP	B-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/14/2002	1/14/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/13/2002	11/13/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
GIACCIO	GIACCIO	NNP	B-NP	O
,	,	,	O	O
CHRISTIAN	CHRISTIAN	NNP	B-NP	O
850-25-16-1	850-25-16-1	CD	I-NP	O
St.	St.	NNP	I-NP	O
Wayne	Wayne	NNP	I-NP	O
,	,	,	O	O
Nevada	Nevada	NNP	B-NP	O
57760	57760	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/26/02	9/26/02	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KAMARA	KAMARA	NNP	B-NP	O
,	,	,	O	O
HANK	HANK	NNP	B-NP	O
EDGARDO	EDGARDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ELAVIL	ELAVIL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QHS	QHS	NN	I-NP	O
CACO3	CACO3	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
.	.	.	O	O

CA	CA	NN	B-NP	O
+	+	SYM	O	O
+	+	SYM	O	O
-RRB-	-RRB-	NN	O	B-protein
-RRB-	-RRB-	HYPH	O	I-protein
625	625	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
15	15	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-DNA
<	<	SYM	O	I-DNA
100	100	CD	B-NP	I-DNA
NIFEREX-150	NIFEREX-150	NN	I-NP	I-DNA
150	150	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
PREDNISONE	PREDNISONE	NNP	I-NP	I-DNA
15	15	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
January	January	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
Take	Take	VB	B-VP	O
prednisone	prednisone	NN	B-NP	O
15mgx3d	15mgx3d	CD	I-NP	O
then	then	RB	B-ADVP	O
12.5	12.5	CD	B-NP	O
mgx3d	mgx3d	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
10mgx3d	10mgx3d	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
7.5	7.5	CD	B-NP	O
mgx3d	mgx3d	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
5mgx3d	5mgx3d	CD	B-NP	O
.	.	.	O	O

ZOCOR	ZOCOR	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

TOPROL	TOPROL	NN	B-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

100	100	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	B-ADJP	O
100	100	CD	B-NP	O
;	;	:	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
500	500	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLYNASE	GLYNASE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
MICRO	MICRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4.5	4.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
NEXIUM	NEXIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	B-protein
X	X	SYM	B-NP	I-protein
2	2	CD	I-NP	I-protein
Days	Day	NNPS	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/26/02	9/26/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POLYSACCHARIDE	POLYSACCHARIDE	NNP	B-NP	O
IRON	IRON	NNP	I-NP	O
COMPLEX	COMPLEX	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
already	already	RB	B-ADVP	O
on	on	IN	B-PP	O
doing	do	VBG	B-VP	O
well	well	RB	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
RETURN	RETURN	NNP	B-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Boulanger	Boulanger	NNP	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
March	March	NNP	I-NP	O
.	.	.	O	O

,	,	,	O	O
No	No	DT	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
r/o	r/o	NN	B-NP	O
mi	mi	NN	I-NP	O
with	with	IN	B-PP	O
RA	RA	NN	B-NP	B-DNA
flare	flare	NN	I-NP	I-DNA
in	in	IN	B-PP	O
B	B	NN	B-NP	O
ankles	ankle	NNS	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
B	B	NNP	I-NP	O
ankle	ankle	NNP	I-NP	O
RA	RA	NNP	I-NP	O
flare	flare	VBD	B-VP	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
RHEUM	RHEUM	NNP	I-NP	O
.	.	.	O	O

ARTHRITIS	ARTHRITIS	NN	B-NP	O
AODM	AODM	NN	I-NP	O
H/O	H/O	NN	I-NP	O
GIB	GIB	NN	I-NP	O
ANEMIA	ANEMIA	NN	I-NP	O
?	?	.	O	O

SYNCOPE	SYNCOPE	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
71	71	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
h/o	h/o	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
with	with	IN	B-PP	O
SSCP	SSCP	NN	B-NP	O
and	and	CC	I-NP	O
B	B	NN	I-NP	O
ankle	ankle	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	VBZ	B-VP	O
4-5	4-5	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
dull	dull	JJ	B-ADJP	O
and	and	CC	O	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
L	L	NN	B-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
said	say	VBD	B-VP	O
if	if	IN	B-SBAR	O
feels	feel	NNS	B-NP	O
like	like	IN	B-PP	O
a	a	DT	B-NP	O
pressure	pressure	NN	I-NP	O
pain	pain	NN	I-NP	O
not	not	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
N/V	N/V	NN	B-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pleuritic	pleuritic	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
similar	similar	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
on	on	IN	B-PP	O
9/17	9/17	CD	B-NP	O
and	and	CC	I-NP	O
5/5/01	5/5/01	CD	I-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
adenosine	adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
neg	neg	NN	B-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
and	and	CC	O	O
demonstrated	demonstrate	VBD	B-VP	O
EF	EF	NN	B-NP	B-protein
>	>	SYM	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
nl	nl	NN	B-NP	B-protein
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
similar	similar	JJ	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
presentation	presentation	NN	B-NP	O
to	to	TO	B-PP	O
TH	TH	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
stable	stable	JJ	B-NP	O
vitals	vital	NNS	I-NP	O
at	at	IN	B-PP	O
presentation	presentation	NN	B-NP	O
and	and	CC	O	O
physical	physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
regurg	regurg	NN	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
cycling	cycling	NN	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
-	-	:	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
flat	flat	JJ	B-NP	O
x	x	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
since	since	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
during	during	IN	B-PP	O
R/O	R/O	NN	B-NP	B-protein
will	will	MD	B-VP	O
D/C	D/C	NN	B-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
reproduced	reproduce	VBN	B-VP	O
if	if	IN	B-SBAR	O
apply	apply	RB	B-NP	O
sternal	sternal	JJ	I-NP	O
pressure-likely	pressure-likely	JJ	I-NP	O
costochondritis	costochondritis	NN	I-NP	O
However	However	RB	B-NP	O
pt	pt	NN	I-NP	O
does	do	VBZ	B-VP	O
describe	describe	VB	I-VP	O
second	second	JJ	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
more	more	JJR	B-NP	O
pressure	pressure	NN	I-NP	O
like	like	IN	B-PP	O
and	and	CC	O	O
might	might	MD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
Pt	Pt	NN	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
now	now	RB	B-ADVP	O
but	but	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
destinguished	destinguishe	VBN	I-VP	O
from	from	IN	B-PP	O
condritis	condritis	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
O2-will	O2-will	NN	B-NP	O
D/C	D/C	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
place	place	VB	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
to	to	TO	B-PP	O
tx	tx	NN	B-NP	O
ankle	ankle	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
sternal	sternal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
including	include	VBG	B-PP	O
lisinopril-will	lisinopril-will	NN	B-NP	O
increase	increase	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
as	as	IN	B-PP	O
BP	BP	NN	B-NP	O
in	in	IN	B-PP	O
160-170s	160-170	NNS	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
xl	xl	NN	I-NP	O
.	.	.	O	O

RA	RA	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
put	put	VB	I-VP	O
pt	pt	NN	B-NP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
15mg	15mg	NN	I-NP	O
to	to	TO	B-PP	O
tx	tx	NN	B-NP	O
ankle	ankle	NN	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
taper	taper	VB	I-VP	O
quickly	quickly	RB	I-VP	O
talked	talk	VBN	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Burgees	Burgees	NNP	I-NP	O
her	her	PRP$	B-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
her	her	PRP$	B-NP	O
condition-he	condition-he	NN	I-NP	O
agrees	agree	VBZ	B-VP	O
with	with	IN	B-PP	O
plan	plan	NN	B-NP	O
Endo-continue	Endo-continue	JJ	I-NP	O
synthroid	synthroid	NN	I-NP	O
as	as	IN	B-PP	O
h/o	h/o	NN	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
,	,	,	O	O
TSH	TSH	NN	B-NP	B-protein
-	-	HYPH	B-ADVP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
T3	T3	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
use	use	VB	I-VP	O
SSI	SSI	NNP	B-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
home	home	NN	B-NP	O
glyburide	glyburide	NN	I-NP	O
and	and	CC	I-NP	O
metformin	metformin	NN	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

GI-tolerating	GI-tolerating	JJ	B-NP	O
po	po	NN	I-NP	O
,	,	,	O	O
continue	continue	JJ	B-NP	O
nexium	nexium	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
Prednisone	Prednisone	NN	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
schedule	schedule	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
of	of	IN	B-PP	O
5mg	5mg	NN	B-NP	O
on	on	IN	B-PP	O
6/26/27	6/26/27	CD	B-NP	O
one	one	CD	I-NP	O
10mg	10mg	CD	I-NP	O
tablet	tablet	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
tablet	tablet	NN	I-NP	O
on	on	IN	B-PP	O
11/10/29	11/10/29	CD	B-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
one	one	CD	I-NP	O
10mg	10mg	CD	I-NP	O
tablet	tablet	NN	I-NP	O
on	on	IN	B-PP	O
1/9/1	1/9/1	CD	B-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
one	one	CD	I-NP	O
5mg	5mg	NN	I-NP	O
tablet	tablet	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
on	on	IN	B-PP	O
1/4/4	1/4/4	CD	B-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
one	one	CD	I-NP	O
5mg	5mg	CD	I-NP	O
tablet	tablet	NN	I-NP	O
on	on	IN	B-PP	O
2/5/7	2/5/7	CD	B-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
then	then	RB	B-ADVP	O
off	off	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
Pt	Pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
home	home	NN	B-NP	O
Physical	Physical	JJ	I-NP	O
Therapy	Therapy	NN	I-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	I-NP	O
Nursing	Nursing	NN	I-NP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WENDT	WENDT	NNP	B-NP	O
,	,	,	O	O
ELDON	ELDON	NNP	B-NP	O
J	J	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
XE662	XE662	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/26/02	9/26/02	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

